{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:24:28Z","timestamp":1780334668911,"version":"3.54.1"},"reference-count":38,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>High rates of thrombosis are present in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Deeper insight into the prothrombotic state is essential to provide the best thromboprophylaxis care. Here, we aimed to explore associations among platelet indices, conventional hemostasis parameters, and viscoelastometry data. This pilot study included patients with severe COVID-19 (n = 21) and age-matched controls (n = 21). Each patient received 100 mg aspirin therapy at the time of blood sampling. Total platelet count, high immature platelet fraction (H-IPF), fibrinogen, D-dimer, Activated Partial Thromboplastin Time, von Willebrand factor antigen and von Willebrand factor ristocetin cofactor activity, plasminogen, and alpha2-antiplasmin were measured. To monitor the aspirin therapy, a platelet function test from hirudin anticoagulated whole blood was performed using the ASPI test by Multiplate analyser. High on-aspirin platelet reactivity (n = 8) was defined with an AUC &gt; 40 cut-off value by ASPI tests. In addition, in vitro viscoelastometric tests were carried out using a ClotPro analyser in COVID-associated thromboembolic events (n = 8) (p = 0.071) nor the survival rate (p = 0.854) showed associations with high on-aspirin platelet reactivity status. The platelet count (p = 0.03), all subjects. COVID-19 patients presented with higher levels of inflammatory markers, compared with the controls, along with evidence of hypercoagulability by ClotPro. H-IPF (%) was significantly higher among non-survivors (n = 18) compared to survivors (p = 0.011), and a negative correlation (p = 0.002) was found between H-IPF and plasminogen level in the total population. The platelet count was significantly higher among patients with high on-aspirin platelet reactivity (p = 0.03). Neither the ECA-A10 (p = 0.008), and ECA-MCF (p = 0.016) were significantly higher, while the tPA-CFT (p &lt; 0.001) was significantly lower among patients with high on-aspirin platelet reactivity. However, only fibrinogen proved to be an independent predictor of hypofibrinolysis in severe COVID-19 patients. In conclusion, a faster developing, more solid clot formation was observed in aspirin \u2018non-responder\u2019 COVID-19 patients. Therefore, an individually tailored thromboprophylaxis is needed to prevent thrombotic complications, particularly in the hypofibrinolytic cluster.<\/jats:p>","DOI":"10.3390\/metabo11120826","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T22:01:11Z","timestamp":1638309671000},"page":"826","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Plasma Fibrinogen Independently Predicts Hypofibrinolysis in Severe COVID-19"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5478-730X","authenticated-orcid":false,"given":"Diana","family":"Schrick","sequence":"first","affiliation":[{"name":"Anesthesiology and Intensive Therapy, Clinical Centre, Medical School, University of P\u00e9cs, 7624 Pecs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"T\u0151k\u00e9s-F\u00fczesi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Centre, Medical School, University of P\u00e9cs, 7624 Pecs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"R\u00e9ger","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Centre, Medical School, University of P\u00e9cs, 7624 Pecs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6149-9787","authenticated-orcid":false,"given":"Tiham\u00e9r","family":"Moln\u00e1r","sequence":"additional","affiliation":[{"name":"Anesthesiology and Intensive Therapy, Clinical Centre, Medical School, University of P\u00e9cs, 7624 Pecs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,30]]},"reference":[{"key":"ref_1","unstructured":"WHO Coronavirus (COVID-19) (2021, July 20). Dashboard|WHO Coronavirus (COVID-19) Dashboard with Vaccination Data. Available online: https:\/\/covid19.who.int\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11239-020-02290-6","article-title":"Immature platelets in patients hospitalized with Covid-19","volume":"51","author":"Cohen","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Inchingolo, A.D., and Inchingolo, A.M. (2021). SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention. Microorganisms, 9.","DOI":"10.3390\/microorganisms9030525"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ulanowska, M., and Olas, B. (2021). Modulation of Hemostasis in COVID-19; Blood Platelets May Be Important Pieces in the COVID-19 Puzzle. Pathogens, 10.","DOI":"10.3390\/pathogens10030370"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/jalm\/jfab042","article-title":"Role of von Willebrand Factor in COVID-19 Associated Coagulopathy","volume":"6","author":"Zhen","year":"2021","journal-title":"J. Appl. Lab. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/jth.14820","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Arachchillage","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/09537104.2020.1768523","article-title":"Hemostatic laboratory derangements in COVID-19 with a focus on platelet count","volume":"31","author":"Amgalan","year":"2020","journal-title":"Platelets"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s13167-020-00208-z","article-title":"Early decrease in blood platelet count is associated with poor prognosis in COVID-19 patients\u2014Indications for predictive, preventive, and personalized medical approach","volume":"11","author":"Zhao","year":"2020","journal-title":"EPMA J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00277-020-04019-0","article-title":"Mechanism of thrombocytopenia in COVID-19 patients","volume":"99","author":"Xu","year":"2020","journal-title":"Ann. Hematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/jth.14879","article-title":"What do monitoring platelet counts in COVID-19 teach us?","volume":"18","author":"Tchachil","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-020-05678-0","article-title":"Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19","volume":"20","author":"Ouyang","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.thromres.2005.09.007","article-title":"A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF)","volume":"118","author":"Abe","year":"2006","journal-title":"Thromb Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/bjh.17656","article-title":"Immature platelets as a biomarker for disease severity and mortality in COVID-19 patients","volume":"194","author":"Welder","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bja.2020.12.010","article-title":"Impaired fibrinolysis in critically ill COVID-19 patients","volume":"126","author":"Bachler","year":"2021","journal-title":"Br. J. Anaesth."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2147\/CIA.S138592","article-title":"Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease","volume":"12","author":"Zhang","year":"2017","journal-title":"Clin. Interv. Aging"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1007\/s12325-021-01803-w","article-title":"Platelet Reactivity and Coagulation Markers in Patients with COVID-19","volume":"38","author":"Bertolin","year":"2021","journal-title":"Adv. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Iacobucci, G. (2021). Covid-19: Aspirin does not improve survival for patients admitted to hospital, trial reports. BMJ, 373.","DOI":"10.1136\/bmj.n1475"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group (2021). Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. Lancet.","DOI":"10.1101\/2021.06.08.21258132"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03401-8","article-title":"Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis","volume":"24","author":"Kruse","year":"2020","journal-title":"Crit. Care"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A meta-analysis","volume":"58","author":"Henry","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40001-020-00432-3","article-title":"Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: A systematic review and meta-analysis","volume":"25","author":"Ghahramani","year":"2020","journal-title":"Eur. J. Med. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ijid.2020.05.055","article-title":"Association of inflammatory markers with the severity of COVID-19: A meta-analysis","volume":"96","author":"Zeng","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"117788","DOI":"10.1016\/j.lfs.2020.117788","article-title":"The role of biomarkers in diagnosis of COVID-19\u2014A systematic review","volume":"254","author":"Kermali","year":"2020","journal-title":"Life Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"104370","DOI":"10.1016\/j.jcv.2020.104370","article-title":"Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19","volume":"127","author":"Liu","year":"2020","journal-title":"J. Clin. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.medmal.2020.03.007","article-title":"C-reactive protein levels in the early stage of COVID-19","volume":"50","author":"Wang","year":"2020","journal-title":"M\u00e9decine Mal. Infect."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Poudel, A., and Poudel, Y. (2021). D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0256744"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/jth.14859","article-title":"D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19","volume":"18","author":"Zhang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","article-title":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy","volume":"191","author":"Lodigiani","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_32","first-page":"1","article-title":"Low level of plasminogen increases risk for mortality in COVID-19 patients","volume":"12","author":"Pacifici","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000512007","article-title":"The Impact of COVID-19 Disease on Platelets and Coagulation","volume":"88","author":"Wool","year":"2021","journal-title":"Pathobiology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bjh.17273","article-title":"Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): Evidence of acute and sustained endothelial cell activation","volume":"192","author":"Ward","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Incir, S., and Komesli, Z. (2021). Immature platelet fraction: Is a novel early predictive marker for disease severity in patients with Covid-19 pneumonia?. Turkish J. Biochem.","DOI":"10.1515\/tjb-2021-0070"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3389\/fneur.2021.666994","article-title":"Novel predictors of future vascular events in post-stroke patients\u2014A pilot study","volume":"12","author":"Schrick","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3233\/CH-190580","article-title":"A novel approach of platelet function test for prediction of attenuated response to clopidogrel","volume":"73","author":"Ezer","year":"2019","journal-title":"Clin Hemorheol Microcirc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/TA.0000000000002963","article-title":"Hypercoagulable viscoelastic blood clot characteristics in critically ill coronavirus disease 2019 patients and associations with thrombotic complications","volume":"90","author":"Roh","year":"2021","journal-title":"J. Trauma Acute Care Surg."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/11\/12\/826\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:37:55Z","timestamp":1760168275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/11\/12\/826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["metabo11120826"],"URL":"https:\/\/doi.org\/10.3390\/metabo11120826","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,30]]}}}